Eurofins · 17 hours ago
Bioanalytical Scientist
Eurofins is an international life sciences company focused on providing a unique range of analytical testing services. The Bioanalytical Scientist will perform biochemical and analytical assays to support protein and antibody characterization in a fast-paced laboratory environment.
BiotechnologyGeneticsHealth CareLife SciencePharmaceutical
Responsibilities
Perform bioanalytical testing on proteins and antibodies, including but not limited to:
Capillary Electrophoresis (CE)
HPLC methods such as SEC and CEX
SDS‑PAGE
UV spectroscopy
Protein A titer assays
ELISA
QPCR
Cell‑based or biochemical bioassays
Record and manage data within laboratory information management systems (LIMS)
Contribute to laboratory investigations and troubleshooting activities
Document experimental procedures, observations, and results in lab notebooks and technical reports
Follow established SOPs, quality standards, and regulatory requirements
Qualification
Required
Bachelor's degree in Biology, Biochemistry, Chemistry, or a related scientific discipline
Minimum of two years of relevant laboratory experience
Strong organizational, computer, and scientific documentation skills
Excellent written and verbal communication abilities with strong attention to detail
Ability to work both independently and collaboratively within a team
Self‑motivated, adaptable, and able to manage multiple tasks simultaneously
Demonstrated ability to learn new techniques, maintain accurate records, and comply with company policies and procedures
Authorization to work in the United States indefinitely without restriction or sponsorship
Benefits
Comprehensive medical coverage, dental, and vision options
Life and disability insurance
401(k) with company match
Paid vacation and holiday
Yearly goal-based bonus & eligibility for merit-based increases
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $586.37M
2025-03-27Post Ipo Debt· $431.4M
2021-10-22Grant· $30M
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase